Page last updated: 2024-11-05

tolazamide and Hemorrhagic Shock

tolazamide has been researched along with Hemorrhagic Shock in 1 studies

Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.

Research Excerpts

ExcerptRelevanceReference
"Hemorrhagic shock is associated with early vasomotor paralysis as well as with early derangements in the intracellular metabolic status."1.29Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. ( Salzman, AL; Szabó, C, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szabó, C1
Salzman, AL1

Other Studies

1 other study available for tolazamide and Hemorrhagic Shock

ArticleYear
Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock.
    Shock (Augusta, Ga.), 1996, Volume: 5, Issue:6

    Topics: Animals; ATP-Binding Cassette Transporters; Blood Pressure; Disease Models, Animal; Glyburide; Heart

1996